Country-Wise Insights: U.S. Leads While Asia and Europe Show Fast Uptake The United States remains the most lucrative market for canine flu therapeutics, driven by high pet adoption rates, increased ...

Miranda Marquit is a staff senior personal finance editor for Buy Side from WSJ. Pets Best receives 4.5 out of 5 stars in our best pet insurance companies rankings. Customize coverage with ...

The owner of a Pittsburgh funeral home was arrested Monday after allegedly stealing more than $650,000 from customers who paid for pet burial and cremation services, throwing their animals in a ...

A funeral home director with offices in Pittsburgh and Natrona Heights is accused of defrauding thousands of pet owners over years, taking their money to give their pets dignified burials and ...

Biotech company Sarepta Therapeutics (NASDAQ:SRPT) will be reporting results tomorrow after market hours. Here’s what to look for. Sarepta Therapeutics beat analysts’ revenue expectations by 4 ...

Unlike the Pets in simulator-style games that apply percentage boosts, each Animal in Grow a Garden has a more varied set of bonuses. These bonuses don’t rely on amplifying specific stats ...

The Pets Go Arcade Clicker Expansion is the 29th patch iteration of the pet-themed RNG universe. Notably, multiple Titanic and Huge Pets debuted in the event world. Furthermore, Clicker Zone ...

Novartis AG has agreed to buy U.S. biotech firm Regulus Therapeutics Inc. in a deal that could be valued at up to $1.7 billion. The Swiss company will pay $7 a share in cash up-front through a ...

Viking Therapeutics is developing drugs for obesity and non-alcoholic fatty liver disease. The company has no revenue and may have none for several years as it works to get drug approval.

Americans are a pet-loving bunch with more than 60% owning at least one pet, according to the American Veterinary Medical Association. The sheer numbers are enormous: Americans treasure almost 90 ...

Sarepta Therapeutics stock is diving after the company released its Q1 results. The company reports quarterly losses of $3.42 per share which missed the analyst consensus estimate of losses of 95 ...